RVMD · Healthcare · Biotechnology
Revolution Medicines’ 60% quarter still commands a premium, but biotech volume is not confirming the move
RVMD added 3.1% in the latest week and remains close to its 52-week high, but participation was below average and Relative Strength has cooled over four weeks.
153.9 USDLatest Close
3.1%1W Return
5.6%4W Return
60.6%12W Return